This is hard to believe, but I also believe at the
Post# of 72440
GI tract relief of Oral Mucositis, Ulcerative Colitis and Proctitis, Crohn's Disease, and a host of other gastrointestinal problems.
Inflammatory issues in the lungs to include Asthma, Bronchitis, and COPD plus a host of other issues.
Encephalitis (brain swelling) and other possible indications to include "leaky brain" which would address Alzheimer's, Dementia, ALS (Lou Gehrig's Disease), Parkinson's, and MS.
Dermatology applications
Eye/ear possible applications
Antibiotic that would be able to handle "superbugs" by destroying the bacteria.
Anti-fungal properties
Antiviral indications to include ALL corona viruses and many other types of viruses by KILLING them thru a new method of action
The above is only a START as to the possible many more indications that will be found in the future for Brilacidin - IMO it could become the standard daily treatment ALL people in the world take to prevent many, many current ailments to mankind.
And to top it off, it does all the above SAFELY.
Now who in their right mind is going to believe any drug will be able to address that spectrum of medical issues?
I have said it before, I believe Brilacidin is the first of many new age drugs to be developed using AI and other new technologies that will propel medicine closer to what was seen on Star Trek than what we see in the world today.
Many will scoff at this, but we oldsters laughed at Dick Tracy comics and his watch in the 50's that pretty much paralleled smart watches of today. Technology is progressing at an ever increasing rate.
Bottom line - The investing public today IMO is not ready to accept such a wondrous drug as Brilacidin and we are among the few that have grasped its potential. As the word spreads thru the highest levels of medicine and Brilacidin is heavily investigated and brought to full fruition, the world will come to recognize its importance and value.
So it is easy to see why I scoff at those that think of IPIX as a stock with the potential of only a few dollars per share.